Tag: company

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

FORT WORTH, Texas, July 3, 2025 /PRNewswire/ -- Four years since launching its first ever pitch competition, the eosera® Foundation is preparing to open...

WOO X, a leading global crypto trading platform, is thrilled to announce that Demo Copy, a cornerstone feature of our social trading product, is now live.

SINGAPORE, July 4, 2025 /PRNewswire/ -- XL Ventures Pte Ltd, a Singapore-headquartered climate tech focused company, has received In-Principle Approval from the Monetary Authority...

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ VANCOUVER, BC, July 3, 2025 /CNW/ - Priyanka Capital Inc. ("Priyanka" or the "Company") is pleased to announce,...

ROAD TOWN, British Virgin Islands, July 3, 2025 /CNW/ - Aura Minerals Inc. (TSX: ORA) (B3: AURA33) and (OTCQX: ORAAF) ("Aura" or the "Company") announced...

TORONTO, July 3, 2025 /CNW/ - PUDO Inc. ("PUDO" or the "Company") (CSE: PDO) (OTCQB: PDPTF), today announced that it will report its first...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

LEATHERHEAD, England, July 4, 2025 /PRNewswire/ -- MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has received its CE mark,...

Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.

Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.

Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support.

Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support.

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Telephone and Data Systems, Inc. (NYSE: TDS), Fluence Energy, Inc. (NASDAQ: FLNC), The Bancorp, Inc. (NASDAQ: TBBK), Zynex, Inc. (NASDAQ: ZYXI). Long-term shareholders of any of these companies who have continuously held shares during the relevant time periods may be able to hold certain officers and directors personally accountable for misconduct and assist in reforming the company’s corporate governance.

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, July 3, 2025 /CNW/ - Cascadia Minerals Ltd. ("Cascadia")...